<
1
Supervalu’s Stock Surges on Save-A-Lot Bid

Supervalu’s (SVU) stock price spiked as much as 9.6% on September 29, 2016. SVU’s rise followed a Reuters report that Onex, a Toronto-based private equity firm, demonstrated interest in acquiring the company’s Save-A-Lot chain.

Chart-01-7-1
How Recent Developments for Merck & Co. May Impact Its Valuation

On September 29, 2016, Merck & Co. (MRK) was trading at a forward PE (price-to-earnings) of ~16.2x, compared to the industry average of 16.0x.

PEP-EPS-3Q16-1
PepsiCo Pops Strong 3Q16 Results, Raises Guidance

Snack and beverage giant PepsiCo (PEP) beat analysts’ earnings and revenue estimates for fiscal 3Q16, which ended on September 3, 2016.

first-debate-run-down-1
Why Isn't the Travel Industry Supporting Donald Trump?

Whether or not Trump wins the presidency, he seems to have already emerged as “baggage” for US travelers. Let’s see how he’s related to the travel industry.

RECENT RESEARCH

1
BlackBerry Outsources Handset Segment, Turns to Software Services

On September 28, 2016, BlackBerry (BBRY) announced its fiscal 2Q17 results and reported non-GAAP revenue of $352 million and GAAP revenue of $334 million. In its earnings call, BlackBerry stated that the company had more than 3,000 enterprise customer wins in the quarter.

valuation-drivers-2-1
Gilead Sciences' Pros and Cons: What to Know before You Invest

Revenues from Gilead Sciences’ HCV franchise are set to decline, primarily due to fewer new starts.

Technology-Sector-Outperforming-SP-500-Index-2016-09-29-1
What Are Morgan Stanley’s Top Technology Stock Picks?

On September 28, 2016, Morgan Stanley (MS) released a list of technology (XLK) stocks that it expects could provide good returns in the months ahead.

fedvolatility
Bonds Have Been the Real Winners: Will It Last?

The December 2015 rate hike was the first since the 2008 global meltdown. Now the Fed is hinting at the first rate hike of the year to come in December 2016.

Graph-13-2-1
Can Novo Nordisk Keep Dominating the Diabetes Care Market?

With 27% of the market share, Novo Nordisk (NVO) currently occupies the number one position in the global diabetes care market.

sp500929-1
Yesterday’s Consumer Pops and Drops: CAG, PEP, F, NKE, and PM

On September 29, 2016, the S&P Consumer Discretionary slightly outperformed the S&P 500 and the S&P Consumer Staples.

returns
Which Upstream Company Would You Be Willing to Bet On?

This series will compare the performances of EQT (EQT), Cabot Oil and Gas (COG), Noble Energy (NBL), and Antero Resources (AR). Antero Resources (AR) performed better than its peers from September 2015 to September 2016, followed by Noble Energy (NBL).

STOCK-PRICE-6-1
Medtronic's Latest Developments and Valuation

Medtronic (MDT) was trading at $85.4 on September 29, with a 50-day moving average of $86.7 and a 200-day moving average of $83.2.

1
Will JACK Continue to Rally after Its New Brunchfast Menu Launch?

To counter McDonald’s (MCD) all-day breakfast promotion, Jack in the Box (JACK) launched its new all-day “brunchfast” menu on September 28, 2016.

STOCK-PRICE-4-1
Investor Updates: What's the Latest from Baxter International?

Baxter’s stock price has risen ~1.8% since the release of its 2Q16 results on July 26, 2016.

Incentive-auction-3-1
Comcast, Charter, and More: Important Updates

Charter Communications (CHTR) is going full speed ahead in a bid to enhance its wireless business.

JA-solars-journey-1
Where Does JA Solar Stand in the Global Solar Industry?

In this series, we’ll look at the key aspects that have set JA Solar apart from its competitors. We’ll take a detailed look at its business model and key products and services.

Stock Performance Of Diamond Offshore and its Peers
Diamond Offshore's Industry Outlook, Analysts' Outlook for DO

Contract drilling service provider Diamond Offshore (DO) is being replaced by Beauty products manufacturer Coty in the S&P 500 index on September 30, 2016.

STOCK-PRICE-5-1
Edwards Lifesciences: Performance, Valuation, Recommendations

Edwards Lifesciences (EW) was trading at $119.3 on September 29, with a 50-day moving average of $116.4 and a 200-day moving average of $105.8.

revenue-projections-2-1
Mallinckrodt’s Projected Performance: What Can You Expect?

Mallinckrodt (MNK) is a specialty pharma company that plans to grow organically by mid-single digits in the long term.

US-Weekly-Rail-2-1
Your Freight Rail Traffic Update for the Week Ended September 24

On September 28, 2016, the Association of American Railroads released the weekly freight rail volume data for the week ended September 24.

green
A Dig into the Truth about Climate-Aware Investing

Green bonds sound like an evolving solution to benefit from the climate change effect. Green bonds are an option to use debt capital markets to fund climate-related projects.

1-VanEck-1
Politics Aside, Generic Drugs Are Key to the Drug Price Debate

The rising costs of prescription drugs attracted attention to generic drugs. It helped reduce medicine costs. Generic drugs are equivalent to branded drugs.

MPLX-is-down-15-percent-ytd-1
Why Is MPLX Underperforming Peers in 2016?

MPLX (MPLX) is currently trading 2% below its 50-day moving average and 5% above its 200-day moving average.

IV
Integrated Energy and Refiners: Insights for Investors

As of September 29, 2016, Calumet Specialty Products Partners (CLMT) had the highest implied volatility among integrated energy companies and refiners.

X

Please select a profession that best describes you: